In 2023 alone, 288,300 new cases of prostate cancer will be diagnosed in the United States, according to the American Cancer Society. And while that number might not seem all that high considering the ...

Of 16,732 patients with metastatic prostate cancer who died after being diagnosed between 2000 and 2016, nearly 17 percent died from other causes, according to a study published Aug. 5 in JAMA Network ...

When Less Can Be More: How the 10-Year Updated Results From the Randomized Controlled AMAROS Trial Should Affect Axillary Management in the Setting of a Positive Node Supported in part by the National ...

While prostate cancer recurrence is a major cause of death in patients receiving localized treatment, there are other significant causes of mortality. While prostate cancer progression or recurrence ...

Men with nonmetastatic prostate cancer lived longer if they followed a healthier lifestyle, despite no reduction in prostate ...

Hormonal changes in a man's aging body can cause the prostate to grow—resulting in urinary problems since the gland is wrapped around the urethra, as seen in this image taken from Asklepios Atlas of ...

Most prostate cancers are found early, through screening, according to the American Cancer Society. Though early prostate cancer usually causes no symptoms, prostate cancers can sometimes cause ...

Orgovyx (relugolix) is a medicine used to treat advanced prostate cancer in adults. Advanced prostate cancer means that the cancer has spread outside of the prostate. Advanced cancers have often come ...

Black men should get an initial prostate cancer test between the ages of 40 and 45, according to new screening guidelines published by the Prostate Cancer Foundation. In the U.S., Black men are at ...